Abstract
Ulcerative colitis and Crohn's disease are characterized by chronic intestinal inflammation. Intestinal bacteria initiate the activation of intestinal inflammatory processes, which are mediated by proinflammatory cytokines and chemokines. In inflammatory bowel disease, intestinal inflammation is not downregulated, in part due to defective or absent inhibitory processes. Studies to date have demonstrated that IL-8, MCP-1, and ENA-78 are highly expressed in the intestinal mucosa in areas of active Crohn's disease and ulcerative colitis. Neutrophils and macrophages in the inflamed intestine synthesize and secrete large amounts of chemokines in patients with inflammatory bowel disease. Increased chemokine expression has also been observed in epithelial cells, endothelial cells, and smooth muscle cells. Future trials of specific agents capable of inhibiting chemokine synthesis and secretion or blocking chemokine–chemokine receptor interaction will be important to study in patients with ulcerative colitis and Crohn's disease.
Similar content being viewed by others
REFERENCES
MacDermott RP: Alterations in the mucosal immune system in ulcerative colitis and Crohn's disease. Med Clin North Am 78:1207–1231, 1994
MacDermott RP: The role of the mucosal immune system in inflammatory bowel disease. In Essentials of Mucosal Immunology, MF Kagnoff, H Kiyono, (eds). San Diego, Academic Press, 1996, pp 321–339
MacDermott RP: Etiology and pathogenesis of inflammatory bowel disease. Curr Opin Gastroenterol 13:302–306, 1997
MacDermott, RP: Immunology of inflammatory bowel disease. Curr Opin Gastroenterol 4:54–67, 1998
Saverymuttu SH, Peters AM, Lavender JP, Chadwick VS, Hodgson HJ: In vivo assessment of granulocyte migration to diseased bowel in Crohn's disease. Gut 26:378–383, 1985
Scholmerich J, Schmidt E, Schumichen C, Billmann P, Schmidt H, Gerok W: Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m hexamethyl propylene amine oxide as leukocyte label. Gastroenterology 95:1287–1293, 1988
Pullman WE, Sullivan PJ, Barrett PJ, Lising J, Booth JA, Doe WF: Assessment of inflammatory bowel disease activity by technetium 99m phagocyte scanning. Gastroenterology 95:989–996, 1988
Baggiolini M, Dewald B, Moser B: Interleukin-8 and related chemotactic cytokines—CXC and CC chemokines. Adv Immunol 55:97–179, 1994
Taub DD, Oppenheim JJ: Chemokines, inflammation and the immune system. Ther Immunol 1:229–246, 1994
Taub DD: Chemokine-leukocyte interactions. The voodoo that they do so well. Cytokine Growth Factor Rev 7:355–376, 1996
Adams DH, Lloyd AR: Chemokines: Leukocyte recruitment and activation cytokines. Lancet 349:490–495, 1997
Baggiolini M, Dewald B, Moser B: Human chemokines: An update. Annu Rev Immunol 15:675–705, 1997
Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K: Properties of the novel proinflammatory supergene intercrine cytokine family. Annu Rev Immunol 9:617–648, 1991
Kelner GS, Kennedy J, Bacon KB, Kleyensteuber S, Largaespada DA, Jenkins NA, Copeland NG, Bazan JF, Moore KW, Schall TJ, et al.: Lymphotactin: A cytokine that represents a new class of chemokine. Science 266:1395–1399, 1994
Eckmann L, Kagnoff MF, Fierer J: Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry. Infect Immun 61:4569–4574, 1993
Jung HC, Eckmann L, Yang SK, Panja A, Fierer J, Morzycka-Wroblewska E, Kagnoff MF: A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 95:55–65, 1995
McCormick BA, Miller SI, Carnes D, Madara JL: Transepithelial signaling to neutrophils by Salmonellae: a novel virulence mechanism for gastroenteritis. Infect Immun 63:2302–2309, 1995
Sheth R, Anderson J, Sato T, Oh B, Hempson SJ, Rollo E, Mackow ER, Shaw RD: Rotavirus stimulates IL-8 secretion from cultured epithelial cells. Virology 221:251–259, 1996
Standiford TJ, Kunkel SL, Basha MA, Chensue SW, Lynch JP, Toews GP, Westwick J, Strieter RM: Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J Clin Invest 86:1945–1953, 1990
Paine R, Rolfe MW, Standiford TJ, Burdick MD, Rollins BJ, Strieter RM: MCP-1 expression by rat type II alveolar epithelial cells in primary culture. J Immunol 150:4561–4570, 1993
Kagnoff MF, Eckmann L: Epithelial cells as sensors for microbial infection. J Clin Invest 100:6–10, 1997
Yang SK, Eckmann L, Panja A, Kagnoff MF: Differential and regulated expression of CXC, CC, and C-chemokines by human colon epithelial cells. Gastroenterology 113:1214–1223, 1997
Elewaut D, Didoanto JA, Kim JM, et al.: Nuclear factor-kB is a central regulator of the epithelial cell proinflammatory gene program after infection with invasive bacteria. Gastroenterology 116:G3071, 1999
Ohno Y, Lee J, Fusunyan RD, MacDermott RP, Sanderson IR: Macrophage inflammatory protein-2: Chromosomal regulation in rat small intestinal epithelial cells. Proc Natl Acad Sci USA 94:10279–10284, 1997
Fusunyan RD, Quinn JJ, Ohno Y, MacDermott, RP, Sanderson IR: Butyrate enhances interleukin-8 secretion by intestinal epithelial cells in response to interleukin-1β and lipopolysaccharide. Pediatr Res 43(1):84–90, 1998
Quinn JJ, Fusunyan RD, MacDermott RP, Sanderson IR: Butyrate switches the pattern of chemokine secretion by intestinal epithelial cells. Gastroenterology 110:A833, 1996
Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm TE, Balish E, Taurog JD, Hammer RE, Wilson KH, Sartor BR: Normal luminal bacteria, especially Bacterioides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest 98:945–953, 1996
Dwinell MB, Eckmann L, Leopard JD, Varki NM, Kagnoff MF: Chemokine Receptor Expression by Human Intestinal Epithelial Cells. Gastroenterology 117:359–367, 1999
Mahida YR, Ceska M, Effenberger F, Kurlak L, Lindley I, Hawkey CJ: Enhanced synthesis of neutrophil activating peptide-1/interleukin-8 in active ulcerative colitis. Clin Sci 82:273–275, 1992
Izzo RS, Witkon K, Chen AI, Hadjiyane C, Weinstein MI, Pellecchia C: Interleukin-8 and neutrophil markers in colonic mucosa from patients with ulcerative colitis. Am J Gastroenterol 87:1447–1452, 1992
Izzo RS, Witkon K, Chen AI, Hadjiyane C, Weinstein MI, Pellecchia C: Neutrophil-activating peptide (interleukin-8) in colonic mucosa from patients with Crohn's disease. Scand J Gastroenterol 28:296–300, 1993
Raab Y, Gerdin B, Ahlstedt S, Hallgren R: Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis. Gut 34:1203–1206, 1993
Kesharvarzian A, Fusunyan RD, D'Astice M, Eiznhamer D, Sanderson IR, MacDermott RP: Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: Evidence for a biological role for IL-8 in inflammation of the colon. Am J Gastroenterol 94:704–712, 1999
Ina K, Kusugami K, Yamaguchi T, Imada A, Hosokawa T, Ohsuga M, Shinoda M, Ando T, Ito K, Yokoyama Y: Mucosal interleukin-8 is involved in neutrophil migration and binding to extracellular matrix in inflammatory bowel disease. Am J Gastroenterol 92:1342–1346, 1997
Mitsuyama K, Toyonaga A, Sasaki E, Watanabe K, Tateishi H, Nishiyama T, Saiki T, Ikeda H, Tsuruta O, Tanikawa K: IL-8 is an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease. Clin Exp Immunol 96:432–436, 1994
Daig R, Andus T, Aschenbrenner E, Falk W, Scholmerich J, Gross V: Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 38:216–222, 1996
Mazzucchelli L, Hauser C, Z'graggen K, Wagner J, Hess M, Laissue JA, Mueller C: Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am J Pathol 144:997–1007, 1994
Izutani R, Ohyanagi H, MacDermott RP: Quantitative PCR for detection of femtogram quantities of interleukin-8 mRNA expression. Microbiol Immunol 38:233–237, 1994
Izutani R, Loh EY, Reinecker HC, Ohno Y, Fusunyan RD, Lichtenstein GR, Rombeau JL, MacDermott RP: Increased expression of interleukin-8 mRNA in ulcerative colitis and Crohn's disease mucosa and epithelial cells. Inflamm Bowel Dis 1:37–47, 1995
Grimm MC, Elsbury SKO, Pavli P, Doe WF: Interleukin 8: Cells of origin in inflammatory bowel disease. Gut 39:90–98, 1996
Arai F, Takahashi T, Furukawa K, Matsushima K, Asakura H: Mucosal expression of interleukin-6 and interleukin-8 messenger RNA in ulcerative colitis and Crohn's disease. Dig Dis Sci 43:2071–2079, 1999
Reinecker HC, Loh EY, Ringler DJ, Mehta A, Rombeau JL, MacDermott RP: Monocyte-chemoattrant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology 108:40–50, 1995
Grimm MS, Elsbury SKO, Pavli P, Doe WF: Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa. J Leukocyte Biol 56:804–812, 1996
Hausmann M, Spottl T, Falk W, Scholmerich J, Andus T, Rogler G: Differential substractive screening of CD33-positive macrophages from normal and inflamed mucosa. Gastroenterology 116:G3186, 1999
Mazzucchelli L, Hauser C, Z'graggen K, Wagner HE, Heiss MW, Laissue JA, Mueller C: Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease. J Pathol 178:201–206, 1996
Wedemeyer J, Lorentz A, Goke M, et al.: Enhanced production of monocyte chemotactic protein 3 in inflammatory bowel disease mucosa. Gut 44:629–635, 1999
Z'Graggen, Walz A, Mazzucchelli L, Streiter RM, Mueller C: The C-X-C chemokine ENA-78 is preferentially expressed in intestinal epithelium in inflammatory bowel disease. Gastroenterology 113:808–816, 1997
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
MacDermott, R.P. Chemokines in the Inflammatory Bowel Diseases. J Clin Immunol 19, 266–272 (1999). https://doi.org/10.1023/A:1020583306627
Issue Date:
DOI: https://doi.org/10.1023/A:1020583306627